Nova Leap Health (NLH) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
13 Jun, 2025Investment highlights and market position
Leading provider in the essential and expanding home care industry, focusing on dementia care and family-centered services.
Completed 20 acquisitions since 2016, with renewed acquisition activity in 2024 and operations in 10 US states and Nova Scotia.
Over 90% of sector players are small businesses, with top three firms holding less than 5% market share, indicating high fragmentation and consolidation potential.
Record adjusted EBITDA in 2023 and $1.7M for Q4 2023–Q3 2024, with increasing gross margins and no bank debt.
Management holds 40% insider ownership, aligning interests with shareholders.
Industry overview and growth drivers
Home care is among the fastest-growing US healthcare sectors, driven by an aging population and chronic disease prevalence.
The at-home care industry is projected to grow at a 4.9% CAGR from 2020 to 2026, with non-medical home care representing 6.4% of the market.
By 2030, over 20% of Americans will be over 65, and dementia patients account for about 70% of Nova Leap's revenue.
Socioeconomic trends are reducing family-provided care, increasing demand for professional home care services.
Business model and services
Focuses on acquiring and growing home care companies, offering both non-medical and skilled home care services.
Non-medical services include dementia care, personal grooming, mobility assistance, medication reminders, errands, and meal prep, paid out-of-pocket.
Skilled home health care includes nursing, therapy, pain and wound management, and is typically government reimbursed.
Latest events from Nova Leap Health
- Record revenue and EBITDA growth in 2025, with robust margins and strong liquidity.NLH
Q4 20256 Mar 2026 - Profitable in-home care provider grows via acquisitions, targeting long-term, sustainable expansion.NLH
Presents at Planet MicroCap Showcase: VEGAS 202524 Nov 2025 - Record Q3 2025 revenue and profitability, with both segments achieving all-time highs.NLH
Q3 202518 Nov 2025 - Record revenue and margin growth in Q2 2025, with strong segment and operational performance.NLH
Q2 202519 Aug 2025 - 10th consecutive positive Adjusted EBITDA, strong cash, and new acquisition despite revenue dip.NLH
Q2 202413 Jun 2025 - Q3 2024 delivered consistent operating results and sets up Nova Leap for further acquisitive growth.NLH
Q3 202413 Jun 2025 - Revenue up 10.3% YoY, but profit metrics down; Nova Scotia leads growth.NLH
Q1 20256 Jun 2025 - Record Adjusted EBITDA and strategic acquisitions drive Nova Leap's growth in 2024.NLH
Q4 20246 Jun 2025